https://medicaex.com/prnewswire/rs-abdi-waluyo-acquires-the-worlds-first-photon-counting-ct-to-improve-clinical-outcomes-for-patients-in-indonesia/ 2023-04-13T14:12:19+00:00 https://medicaex.com/prnewswire/nccn-annual-conference-brings-up-important-questions-for-improving-cancer-care/ 2023-04-13T14:12:15+00:00 https://medicaex.com/prnewswire/biosion-initiates-phase-ii-clinical-trial-of-bsi-045b-in-atopic-dermatitis/ 2023-04-13T12:12:23+00:00 https://medicaex.com/prnewswire/sirnaomics-launches-phase-i-clinical-trial-for-galnac-factor-xi-program/ 2023-04-13T12:12:16+00:00 https://medicaex.com/prnewswire/ew-group-shines-at-12th-a4m-symposium-2023-all-on-bioregen-optimization-workshop/ 2023-04-13T05:12:12+00:00 https://medicaex.com/prnewswire/specialised-therapeutics-signs-partnership-agreement-with-akeso-inc-and-cttq-akeso-to-commercialise-new-anti-pd1-antibody-in-australia-and-southeast-asia/ 2023-04-13T04:12:13+00:00 https://medicaex.com/prnewswire/picarro-cavity-ring-down-spectroscopy-successfully-validated-under-epas-otm-47-to-measure-ethylene-oxide-emissions-in-real-time-from-stationary-sources/ 2023-04-13T03:12:18+00:00 https://medicaex.com/prnewswire/world-brain-day-2023-putting-a-spotlight-on-brain-health-and-disability/ 2023-04-13T03:12:14+00:00 https://medicaex.com/prnewswire/tianlong-announces-global-release-of-geneflex-nucleic-acid-extractor-and-gentier-mini-real-time-pcr-system/ 2023-04-13T02:12:17+00:00 https://medicaex.com/prnewswire/inotiv-applauded-by-frost-sullivan-as-key-competitor-in-the-bio-analytical-testing-services-market/ 2023-04-13T00:12:14+00:00 https://medicaex.com/prnewswire/metabolon-launches-bile-acids-and-short-chain-fatty-acids-targeted-panels-to-advance-understanding-of-microbiome-and-gut-metabolome-in-health-and-disease/ 2023-04-12T22:12:22+00:00 https://medicaex.com/prnewswire/boan-biotechs-biologics-license-application-for-boyounuo-bevacizumab-injection-accepted-in-brazil/ 2023-04-12T22:12:15+00:00 https://medicaex.com/prnewswire/oncusp-therapeutics-showcases-potent-anti-tumor-activity-of-its-cdh6-adc-at-aacr-annual-meeting-2023/ 2023-04-12T16:12:13+00:00 https://medicaex.com/prnewswire/acm-biolabs-further-strengthens-leadership-appoints-david-lawrence-to-board-of-directors/ 2023-04-12T14:12:15+00:00 https://medicaex.com/prnewswire/edanz-acquires-scribendi/ 2023-04-12T14:12:10+00:00 https://medicaex.com/prnewswire/health-in-tech-partners-with-6-degrees-health-to-accelerate-implementation-of-level-funded-health-plans-with-transparency-control-and-predictability/ 2023-04-12T13:12:11+00:00 https://medicaex.com/prnewswire/chitose-group-obtains-funding-from-japanese-government-affiliated-nedo-for-green-innovation-fund-of-usd400m-range/ 2023-04-12T07:12:12+00:00 https://medicaex.com/prnewswire/gc-genome-kaist-team-announces-publication-of-a-groundbreaking-ai-based-liquid-biopsy-technology-for-multi-cancer-early-detection-and-localization-in-nature-communications/ 2023-04-12T04:12:21+00:00 https://medicaex.com/prnewswire/lynk-pharmaceuticals-announces-positive-results-for-lnk01003-in-phase-i-trial-in-healthy-subjects-2/ 2023-04-12T03:12:21+00:00 https://medicaex.com/prnewswire/discovery-life-sciences-acquires-reachbio-research-labs/ 2023-04-11T14:12:15+00:00 https://medicaex.com/prnewswire/actinogen-presents-positive-phase-2a-xanamem-data-in-at-adpd-alzheimers-and-parkinsons-diseases-conference/ 2023-04-11T13:12:23+00:00 https://medicaex.com/prnewswire/asieris-subsidiary-makes-significant-progress-in-its-commercialization-strategy-by-obtaining-the-drug-distribution-license/ 2023-04-11T13:12:16+00:00 https://medicaex.com/prnewswire/origin-agritech-gmo-corn-hybrid-is-the-one-and-only-triple-stack-trait-corn-selected-for-national-demo-plot-being-grown-there-in-anticipation-of-2023-commercial-launch/ 2023-04-11T13:12:11+00:00 https://medicaex.com/prnewswire/biosyngen-received-china-nmpa-ind-approval-for-its-t-cell-redirection-therapy-targeting-ebv-positive-lymphoma/ 2023-04-11T11:12:14+00:00 https://medicaex.com/prnewswire/bitbiome-and-kaken-pharmaceuticals-sign-joint-research-agreement-on-the-discovery-of-drugs-for-infectious-diseases/ 2023-04-11T01:12:23+00:00 https://medicaex.com/prnewswire/boao-forum-for-asia-enters-the-healthcare-sector/ 2023-04-11T00:12:18+00:00 https://medicaex.com/prnewswire/cooperation-agreement-concluded-between-biokangtai-and-biotis/ 2023-04-11T00:12:14+00:00 https://medicaex.com/prnewswire/croma-pharma-further-strengthening-its-portfolio-with-philart-biostimulators-2/ 2023-04-10T23:12:19+00:00 https://medicaex.com/prnewswire/antengene-announces-first-patient-dosed-with-claudin-18-2-antibody-drug-conjugate-atg-022-for-the-treatment-of-patients-with-advanced-or-metastatic-solid-tumors-in-australia/ 2023-04-10T21:12:25+00:00 https://medicaex.com/prnewswire/sisram-medical-expands-footprint-in-mainland-china-acquires-giant-medical-aesthetic-distributor-photonmed/ 2023-04-10T12:12:29+00:00 https://medicaex.com/prnewswire/anpac-bio-medical-science-announces-closing-of-3-0-million-registered-direct-offering/ 2023-04-10T12:12:25+00:00 https://medicaex.com/prnewswire/jw-therapeutics-announces-ind-approval-for-the-clinical-trial-of-relma-cel-in-patients-with-moderately-or-severely-refractory-systemic-lupus-erythematosus/ 2023-04-10T12:12:24+00:00 https://medicaex.com/prnewswire/histoindex-embarks-on-partnership-with-vcus-stravitz-sanyal-institute-for-liver-disease-and-metabolic-health-in-the-study-of-liver-diseases/ 2023-04-10T12:12:24+00:00 https://medicaex.com/prnewswire/nona-biosciences-enters-into-collaboration-agreement-with-exevir-bio/ 2023-04-10T11:12:14+00:00 https://medicaex.com/prnewswire/kintor-pharma-announces-completion-of-subject-enrollment-in-phase-iii-clinical-trial-of-kx-826-for-treatment-of-male-androgenetic-alopecia-in-china/ 2023-04-10T03:12:22+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-new-drug-application-acceptance-by-singapore-hsa-for-nefecon-for-the-treatment-of-primary-iga-nephropathy/ 2023-04-10T03:12:14+00:00 https://medicaex.com/prnewswire/croma-pharma-further-strengthening-its-portfolio-with-philart-biostimulators/ 2023-04-10T01:12:18+00:00 https://medicaex.com/prnewswire/biorchestra-expands-executive-leadership-team-with-the-appointment-of-david-oxley-as-chief-business-officer/ 2023-04-10T01:12:13+00:00 https://medicaex.com/prnewswire/grey-wolf-therapeutics-announces-dosing-of-first-patient-in-phase-1-2-clinical-study-of-grwd5769-in-patients-with-advanced-solid-tumours/ 2023-04-07T08:12:22+00:00 https://medicaex.com/prnewswire/luye-pharma-and-duopharma-reach-strategic-partnership-to-expand-accessibility-of-cholesterol-management-products-in-malaysia/ 2023-04-07T08:12:14+00:00 https://medicaex.com/prnewswire/bridgewest-group-launches-novacina-new-sterile-injectable-cdmo/ 2023-04-07T02:12:16+00:00 https://medicaex.com/prnewswire/histosonics-announces-first-ever-kidney-tumor-treatment-using-histotripsy/ 2023-04-07T01:12:18+00:00 https://medicaex.com/prnewswire/zylox-tonbridge-announces-financial-results-for-2022-revenue-increases-by-87-8-yoy-to-rmb-334-million-and-gross-profit-reaches-rmb-253-million/ 2023-04-07T01:12:18+00:00 https://medicaex.com/prnewswire/indivumed-evolves-into-indivumed-therapeutics-to-focus-on-data-and-ai-driven-advancement-of-precision-oncology/ 2023-04-07T01:12:14+00:00 https://medicaex.com/prnewswire/standigm-and-institut-pasteur-korea-identify-drug-candidates-for-resistant-tuberculosis-thanks-to-right-foundation-grant/ 2023-04-07T00:12:15+00:00 https://medicaex.com/prnewswire/goodwin-biotechnology-inc-gbi-announces-first-commercial-contract-signing/ 2023-04-06T23:12:16+00:00 https://medicaex.com/prnewswire/wondercise-to-announce-the-new-face-of-signature-live-motion-matching-technology-at-fibo-2023-a-revolutionary-fitness-experience-with-wearables-and-live-content/ 2023-04-06T15:12:14+00:00 https://medicaex.com/prnewswire/img-launches-new-plan-for-expats-globally-mobile-citizens-global-prima-medical-insurance/ 2023-04-06T14:12:14+00:00 https://medicaex.com/prnewswire/ulab-and-maris-list-further-partner-to-maximize-savings-for-mutual-members/ 2023-04-06T13:12:13+00:00 https://medicaex.com/prnewswire/gc-cell-obtains-anti-bribery-management-system-certification/ 2023-04-06T11:12:10+00:00 https://medicaex.com/prnewswire/zimmer-biomets-rosa-hip-with-one-planner-hip-awarded-orthopaedic-product-innovation-of-the-year-by-healthcare-asia-medtech-awards-2023/ 2023-04-06T02:12:20+00:00 https://medicaex.com/prnewswire/latest-updates-of-6-vivas-portfolio-companies/ 2023-04-05T12:12:21+00:00 https://medicaex.com/prnewswire/assure-tech-launches-a-new-platform-comprehensive-health-solution/ 2023-04-05T10:12:13+00:00 https://medicaex.com/prnewswire/broncus-medical-02216-hk-announces-annual-results-for-2022/ 2023-04-05T02:12:24+00:00 https://medicaex.com/prnewswire/cambrex-opens-new-stability-storage-facility-in-belgium/ 2023-04-05T02:12:19+00:00 https://medicaex.com/prnewswire/amplify-health-asia-pte-limited-appoints-david-frankenfield-as-chief-data-officer/ 2023-04-05T02:12:13+00:00 https://medicaex.com/prnewswire/bridgewest-group-completes-acquisition-of-sterile-injectable-manufacturing-plant-in-western-australia-from-pfizer/ 2023-04-05T01:12:18+00:00 https://medicaex.com/prnewswire/havas-health-you-bolsters-offerings-in-apac-with-key-expansions-promotions-across-region/ 2023-04-04T22:12:12+00:00 https://medicaex.com/prnewswire/lifetech-reports-steady-growth-of-32-5percent-in-net-profit-attributable-to-owners-of-the-company-in-2022/ 2023-04-04T21:12:24+00:00 https://medicaex.com/prnewswire/dsm-and-firmenich-have-obtained-all-competition-clearances/ 2023-04-04T14:12:15+00:00 https://medicaex.com/prnewswire/tavneos-avacopan-included-in-updated-eular-recommendations-for-the-management-of-aav/ 2023-04-04T12:12:35+00:00 https://medicaex.com/prnewswire/acepodia-to-present-preclinical-data-of-gamma-delta-t-cell-therapy-candidate-ace2016-an-off-the-shelf-egfr-targeting-%ce%b3%ce%b42-t-cell-therapy-against-egfr-expressing-solid-tumors/ 2023-04-04T12:12:35+00:00 https://medicaex.com/prnewswire/haemalogix-to-present-final-data-from-anti-kma-car-t-preclinical-studies-at-aacr/ 2023-04-04T12:12:35+00:00 https://medicaex.com/prnewswire/lynk-pharmaceuticals-announces-positive-results-for-lnk01003-in-phase-i-trial-in-healthy-subjects/ 2023-04-04T12:12:25+00:00 https://medicaex.com/prnewswire/gc-cell-and-new-management-embarking-on-a-new-chapter/ 2023-04-04T12:12:25+00:00 https://medicaex.com/prnewswire/harbour-biomed-reports-full-year-2022-financial-results/ 2023-04-04T12:12:25+00:00 https://medicaex.com/prnewswire/cbc-group-appoints-healthcare-veteran-abbas-hussain-as-operating-partner/ 2023-04-04T11:12:20+00:00 https://medicaex.com/prnewswire/aahrpp-accredits-two-more-research-organizations-including-another-in-china/ 2023-04-04T07:12:17+00:00 https://medicaex.com/prnewswire/hugel-appointed-suk-yong-cha-as-executive-chairman-and-chairman-of-the-board-accelerating-transformation-into-a-global-top-tier-company/ 2023-04-04T02:12:18+00:00 https://medicaex.com/prnewswire/amaris-b-clinic-wins-merz-aesthetics-golden-record-local-injectables-award-in-2023-2/ 2023-04-04T02:12:17+00:00 https://medicaex.com/prnewswire/i-mab-provides-business-and-corporate-updates-and-reports-financial-results-for-the-year-ended-december-31-2022/ 2023-04-04T01:12:17+00:00 https://medicaex.com/prnewswire/bioduro-sundia-wins-life-sciences-review-top-10-bpo-award/ 2023-04-04T01:12:16+00:00 https://medicaex.com/prnewswire/dr-pradeep-sethi-of-eugenix-hair-sciences-chosen-scientific-director-at-the-prestigious-6th-world-fue-institute-2023-workshop-in-thailand/ 2023-04-04T00:12:17+00:00 https://medicaex.com/prnewswire/anpac-bio-medical-science-enters-into-asset-purchase-agreement-with-easy-hundred-inc/ 2023-04-03T14:12:12+00:00 https://medicaex.com/prnewswire/timekettle-ai-translator-earbuds-empower-international-medical-workers-2/ 2023-04-03T09:12:12+00:00 https://medicaex.com/prnewswire/perisai-paves-the-way-in-asia-introducing-voice-and-behavioral-risk-assessment-for-insurance-and-health-sectors/ 2023-04-03T08:12:13+00:00 https://medicaex.com/prnewswire/ablaze-pharmaceuticals-plans-development-of-innovative-gpc3-targeted-radiopharmaceutical-therapy-for-liver-cancer-in-greater-china/ 2023-04-03T07:12:18+00:00 https://medicaex.com/prnewswire/mallinckrodt-announces-reimbursement-approval-in-japan-for-the-cellex-extracorporeal-photopheresis-ecp-system-for-the-treatment-of-chronic-graft-versus-host-disease-cgvhd/ 2023-04-03T05:12:19+00:00 https://medicaex.com/prnewswire/genscript-biotech-reports-2022-annual-results/ 2023-04-03T05:12:17+00:00 https://medicaex.com/prnewswire/tiens-group-attends-boao-forum-for-asia-annual-conference-2023/ 2023-04-03T03:12:13+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-financial-results-for-full-year-ended-december-31-2022/ 2023-04-01T02:12:19+00:00 https://medicaex.com/prnewswire/nadclinic-group-biostarks-and-do-not-age-announce-exclusive-partnership-to-revolutionise-personalised-longevity/ 2023-03-31T17:12:20+00:00 https://medicaex.com/prnewswire/henlius-2022-annual-results-significant-achievements-in-commercialisation-surged-to-rmb3-2-billion-in-revenues/ 2023-03-31T17:12:20+00:00 https://medicaex.com/prnewswire/kintor-pharma-announces-2022-annual-results-and-recent-business-progress/ 2023-03-31T16:12:22+00:00 https://medicaex.com/prnewswire/scivita-medical-enters-into-strategic-agreement-with-boston-scientific-in-china/ 2023-03-31T12:12:23+00:00 https://medicaex.com/prnewswire/luxury-beauty-advisory-swiss-reju-strengthens-body-contouring-services-with-new-2-45ghz-diathermy-technology/ 2023-03-31T12:12:12+00:00 https://medicaex.com/prnewswire/timekettle-ai-translator-earbuds-empower-international-medical-workers/ 2023-03-31T12:12:11+00:00 https://medicaex.com/prnewswire/yunkang-group-announces-first-annual-results-since-listing/ 2023-03-31T06:12:16+00:00 https://medicaex.com/prnewswire/acceptance-period-extended-pending-indian-competition-clearance-until-no-later-than-12-may-2023/ 2023-03-31T06:12:12+00:00 https://medicaex.com/prnewswire/just-three-months-into-2023-united-imaging-says-four-new-scanners-in-multiple-imaging-modalities-are-now-commercially-available-in-the-united-states/ 2023-03-31T02:12:22+00:00 https://medicaex.com/prnewswire/img-travel-outlook-survey-predicts-continued-surge-of-international-travel-in-2023/ 2023-03-31T02:12:17+00:00 https://medicaex.com/prnewswire/acrobiosystems-new-strategic-focus-streamlining-the-transition-from-preclinical-development-to-commercialization-2/ 2023-03-31T00:12:19+00:00 https://medicaex.com/prnewswire/turn-biotechnologies-introduces-its-dermatology-platform-to-the-european-aesthetic-community-at-amwc/ 2023-03-30T23:12:19+00:00 https://medicaex.com/prnewswire/acrobiosystems-new-strategic-focus-streamlining-the-transition-from-preclinical-development-to-commercialization/ 2023-03-30T19:12:17+00:00 https://medicaex.com/prnewswire/viva-biotech-announced-2022-annual-results/ 2023-03-30T17:12:11+00:00 https://medicaex.com/prnewswire/bimini-health-tech-acquires-exclusive-license-to-acellular-dermal-matrix-product-portfolio/ 2023-03-30T16:12:22+00:00 https://medicaex.com/prnewswire/dxvx-co-ltd-s-affiliated-company-oxford-vacmedix-ovm-successfully-completed-phase-1a-in-clinical-trial-of-novel-cancer-vaccine-ovm-200/ 2023-03-30T16:12:17+00:00 https://medicaex.com/prnewswire/7-out-of-10-gen-z-will-keep-being-vegan-in-the-next-5-years-gen-z-is-leading-the-veganism-trend-data-says/ 2023-03-30T16:12:11+00:00 https://medicaex.com/prnewswire/seegene-declares-to-share-syndromic-pcr-technologies-to-prevent-future-pandemics/ 2023-03-30T15:12:40+00:00 https://medicaex.com/prnewswire/gc-creates-innovation-for-a-better-quality-of-life-for-the-world-using-high-quality-recycled-plastic-resins-of-food-grade-level-guaranteed-safe-by-fda/ 2023-03-30T15:12:19+00:00 https://medicaex.com/prnewswire/picarro-and-lesni-partner-to-deliver-comprehensive-ethylene-oxide-monitoring-solutions-to-sterilization-facilities-worldwide/ 2023-03-30T14:12:23+00:00 https://medicaex.com/prnewswire/clear-medical-imaging-and-see-mode-technologies-announce-partnership-via-curelabs-innovation-hub/ 2023-03-30T14:12:23+00:00 https://medicaex.com/prnewswire/discovery-life-sciences-installs-worlds-largest-commercial-fleet-of-novaseq-x-plus-systems-to-accelerate-genomic-research-with-unprecedented-speed-and-cost-efficiency/ 2023-03-30T14:12:17+00:00 https://medicaex.com/prnewswire/luxury-membership-5-stars-medical-club-signs-agreement-to-serve-as-sponsor-to-ayumi-hamasaki-25th-anniversary-live/ 2023-03-30T14:12:12+00:00 https://medicaex.com/prnewswire/bj-bioscience-announces-clinical-collaboration-with-msd-to-evaluate-bj-001-in-combination-with-keytruda-pembrolizumab/ 2023-03-30T13:12:27+00:00 https://medicaex.com/prnewswire/zhongchao-inc-announces-launch-of-health-education-intelligent-content-production-platform/ 2023-03-30T13:12:12+00:00 https://medicaex.com/prnewswire/clear-medical-imaging-and-see-mode-technologies-announce-partnership-via-curelabs-innovation-hub-2/ 2023-03-30T07:12:21+00:00 https://medicaex.com/prnewswire/great-place-to-work-unveils-best-workplaces-in-the-inaugural-singapore-healthcare-and-biopharma-list-2023/ 2023-03-30T05:12:16+00:00 https://medicaex.com/prnewswire/jw-therapeutics-announces-its-cell-immunotherapy-drugs-have-successfully-benefited-406-patients/ 2023-03-30T01:12:19+00:00 https://medicaex.com/prnewswire/noul-co-ltd-the-right-foundation-commences-research-and-development-for-supporting-malaria-control/ 2023-03-30T00:12:25+00:00 https://medicaex.com/prnewswire/jinghao-partners-with-fosun-trade-for-hearing-aids-in-the-global-area/ 2023-03-30T00:12:22+00:00 https://medicaex.com/prnewswire/genfleet-receives-ema-approval-for-phase-ib-ii-study-of-gfh925-kras-g12c-inhibitor-in-combination-with-erbitux-cetuximab-treating-patients-with-advanced-nsclc-in-first-line-setting/ 2023-03-30T00:12:18+00:00 https://medicaex.com/prnewswire/fosun-pharma-announces-its-15th-corporate-social-responsibility-report-continuous-innovation-for-the-benefit-of-the-public/ 2023-03-30T00:12:16+00:00 https://medicaex.com/prnewswire/transcentas-osemitamab-tst001-targeting-claudin18-2-granted-orphan-drug-designation-for-treatment-of-pancreatic-cancer/ 2023-03-30T00:12:16+00:00 https://medicaex.com/prnewswire/hanall-biopharma-assigns-su-jin-park-as-co-ceo-to-drive-next-phase-of-growth/ 2023-03-30T00:12:16+00:00 https://medicaex.com/prnewswire/athos-therapeutics-receives-regulatory-approval-to-commence-phase-i-clinical-trial-of-ath-063/ 2023-03-29T20:12:17+00:00 https://medicaex.com/prnewswire/jolly-good-and-harvard-university-hospital-collaborate-on-medical-vr-full-scale-entry-into-the-u-s-market/ 2023-03-29T17:14:07+00:00 https://medicaex.com/prnewswire/innovent-announces-2022-annual-results-and-business-updates/ 2023-03-29T17:14:02+00:00 https://medicaex.com/prnewswire/pm-lee-receives-a-first-hand-update-by-biosyngen-on-its-progress-in-cell-therapy/ 2023-03-29T15:12:15+00:00 https://medicaex.com/prnewswire/biorchestra-pens-a-pact-worth-up-to-861m-for-central-nervous-systemcns-targeted-polymeric-nanoparticle-for-intravenous-delivery-of-nucleic-acid-therapies/ 2023-03-29T14:12:26+00:00 https://medicaex.com/prnewswire/dignitana-enters-hong-kong-market-with-leading-distributor-science-international-corporation/ 2023-03-29T14:12:22+00:00 https://medicaex.com/prnewswire/china-life-insurance-company-limited-announces-2022-annual-results-h-shares/ 2023-03-29T14:12:11+00:00 https://medicaex.com/prnewswire/apacmed-names-eversana-knowledge-partner-to-shape-digital-health-reimbursement-framework-across-region/ 2023-03-29T13:12:23+00:00 https://medicaex.com/prnewswire/zylox-tonbridge-assisted-turkish-hospitals-in-post-earthquake-recovery/ 2023-03-29T13:12:22+00:00 https://medicaex.com/prnewswire/pulnovo-medical-announces-3-year-follow-up-results-from-padn-5-at-tht-2023-the-medical-device-maker-breaks-new-ground-in-heart-failure-treatment/ 2023-03-29T11:12:16+00:00 https://medicaex.com/prnewswire/the-first-case-of-covid-pregnant-mother-in-guangzhou-was-successfully-delivered-by-cesarean-section-and-the-newborn-was-in-good-condition-doctors-treat-pregnant-covid-19-patient-under-quarantine-prot/ 2023-03-29T09:12:14+00:00 https://medicaex.com/prnewswire/wuxi-biologics-congratulates-amicus-therapeutics-on-european-commission-approval-for-pombiliti-in-patients-with-late-onset-pompe-disease/ 2023-03-29T06:12:17+00:00 https://medicaex.com/prnewswire/pharmablock-receives-2023-acs-cmo-excellence-in-green-chemistry-award/ 2023-03-29T06:12:17+00:00 https://medicaex.com/prnewswire/pharming-announces-us-fda-approval-of-joenja-leniolisib-as-the-first-and-only-treatment-indicated-for-apds/ 2023-03-29T00:12:25+00:00 https://medicaex.com/prnewswire/tigermed-reports-full-year-2022-results/ 2023-03-29T00:12:16+00:00 https://medicaex.com/prnewswire/sirnaomics-announces-2022-annual-results/ 2023-03-29T00:12:16+00:00 https://medicaex.com/prnewswire/verbal-beginnings-partners-with-the-clinician-to-launch-a-patient-reported-outcomes-program-for-children-with-autism-spectrum-disorder/ 2023-03-28T19:12:18+00:00 https://medicaex.com/prnewswire/antengene-announces-results-for-full-year-2022-with-updates-highlighting-a-sales-revenue-reaching-5-6-times-year-over-year-and-accelerated-global-innovation/ 2023-03-28T14:12:17+00:00 https://medicaex.com/prnewswire/new-study-reveals-clinical-instability-predicts-psychiatric-hospitalization/ 2023-03-28T14:12:17+00:00 https://medicaex.com/prnewswire/healthcare-revolution-medical-tourism-and-the-american-dream/ 2023-03-28T14:12:12+00:00 https://medicaex.com/prnewswire/profoundbio-highlights-broad-antitumor-activity-in-preclinical-models-and-trial-in-progress-for-pro1184-at-aacr-2023-annual-meeting/ 2023-03-28T13:12:27+00:00 https://medicaex.com/prnewswire/see-mode-technologies-secures-regulatory-approvals-for-its-ai-powered-software-that-automatically-analyses-and-reports-breast-thyroid-ultrasound-scans-in-australia-and-new-zealand/ 2023-03-28T13:12:24+00:00 https://medicaex.com/prnewswire/fosun-pharma-announces-2022-annual-results-achieved-steady-growth-with-revenue-from-record-high-innovative-products-and-global-commercialization-capability-improvement/ 2023-03-28T13:12:19+00:00 https://medicaex.com/prnewswire/wat-medical-enterprise-initiates-red-cross-charity-campaign-drawing-on-part-of-revenue-from-its-new-product/ 2023-03-28T11:12:54+00:00 https://medicaex.com/prnewswire/boan-biotech-announces-2022-financial-results/ 2023-03-28T11:12:34+00:00 https://medicaex.com/prnewswire/berry-genomics-and-ajlan-bros-holding-subsidiaries-establish-a-joint-venture-to-support-vision-2030/ 2023-03-28T08:12:17+00:00 https://medicaex.com/prnewswire/jacobio-announces-clinical-collaboration-to-evaluate-cd73-monoclonal-antibody-jab-bx102-in-combination-with-keytruda-pembrolizumab-for-patients-with-cancer/ 2023-03-28T07:12:29+00:00 https://medicaex.com/prnewswire/first-in-class-mabwell-announces-the-tga-approval-of-9mw3811-for-ind/ 2023-03-28T07:12:21+00:00 https://medicaex.com/prnewswire/bd-and-astar-collaborate-to-advance-ultra-high-dimensional-analysis-in-flow-cytometry-for-immunology-research/ 2023-03-28T07:12:19+00:00 https://medicaex.com/prnewswire/pharmablock-opens-new-rd-facility-in-pennsylvania-expanding-capacity-to-deliver-gmp-projects/ 2023-03-28T06:12:20+00:00 https://medicaex.com/prnewswire/amway-applauded-by-frost-sullivan-for-capitalizing-on-innovative-competitive-strategies-to-drive-differentiation-in-its-home-water-treatment-solution-in-apac/ 2023-03-28T06:12:13+00:00 https://medicaex.com/prnewswire/280bio-provides-update-on-the-kras-inhibitor-teb-17231-at-the-2023-aacr-annual-meeting/ 2023-03-28T05:12:29+00:00 https://medicaex.com/prnewswire/ys-biopharmas-pika-recombinant-covid-19-vaccine-demonstrates-superior-antibody-neutralization-responses-compared-to-inactivated-covid-19-vaccine-in-phase-ii-head-to-head-clinical-study/ 2023-03-28T05:12:20+00:00 https://medicaex.com/prnewswire/kintor-pharmas-kx-826-and-gt20029-for-treatment-of-androgenetic-alopecia-aga-and-acne-presented-at-aad-2023/ 2023-03-28T02:12:28+00:00 https://medicaex.com/prnewswire/everest-medicines-receives-full-upfront-payment-from-gilead-for-trodelvy-related-transaction-boosting-pro-forma-cash-reserves/ 2023-03-28T02:12:20+00:00 https://medicaex.com/prnewswire/antengene-announces-five-upcoming-presentations-at-the-2023-american-association-for-cancer-research-annual-meeting/ 2023-03-28T01:12:30+00:00 https://medicaex.com/prnewswire/keymed-biosciences-announces-2022-annual-results-efficiently-promotes-clinical-progress-proactively-develops-global-strategic-collaboration/ 2023-03-28T01:12:30+00:00 https://medicaex.com/prnewswire/bioduro-sundia-announces-formation-of-scientific-advisory-board/ 2023-03-28T01:12:19+00:00 https://medicaex.com/prnewswire/brii-biosciences-provides-corporate-update-and-reports-full-year-2022-financial-results/ 2023-03-27T15:12:21+00:00 https://medicaex.com/prnewswire/hanmi-pharmaceuticals-combination-drug-for-dyslipidemia-treatment-rosuzet-confirmed-non-inferiority-efficacy-and-safety-compared-to-monotherapy-in-the-lancet-european-heart-journal/ 2023-03-27T13:12:29+00:00 https://medicaex.com/prnewswire/clarivate-announces-gordon-samson-as-president-intellectual-property-and-nominates-dr-saurabh-saha-as-new-independent-director/ 2023-03-27T12:12:19+00:00 https://medicaex.com/prnewswire/northumbria-healthcare-nhsft-and-c-polar-technologies-combine-innovation-in-widely-acclaimed-hub/ 2023-03-27T10:12:19+00:00 https://medicaex.com/prnewswire/anpac-bio-medical-science-granted-continued-listing-by-nasdaq-hearing-panel-subject-to-meeting-the-equity-rule-on-or-before-july-12-2023/ 2023-03-27T00:12:19+00:00 https://medicaex.com/prnewswire/symbyx-announces-promising-sydney-adventist-hospital-clinical-trial-results-for-parkinsons-using-the-symbyx-neuro-a-new-light-therapy-wellness-helmet/ 2023-03-24T18:12:29+00:00 https://medicaex.com/prnewswire/global-heart-hub-and-the-global-coalition-on-aging-launch-a-global-position-paper-on-heart-valve-disease-hvd-and-the-healthy-aging-agenda/ 2023-03-24T18:12:21+00:00 https://medicaex.com/prnewswire/generations-connect-project-aims-to-help-boost-the-well-being-of-10000-elderly/ 2023-03-24T13:12:19+00:00 https://medicaex.com/prnewswire/orion-health-strengthens-north-american-operations-with-new-technology-and-leadership/ 2023-03-24T13:12:14+00:00 https://medicaex.com/prnewswire/gccl-develops-pbmc-resource-management-system/ 2023-03-24T12:12:28+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-signing-of-an-mou-for-strategic-cooperation-with-guangdong-academy-of-medical-sciences-in-renal-diseases/ 2023-03-24T12:12:19+00:00 https://medicaex.com/prnewswire/111-inc-announces-fourth-quarter-and-fiscal-year-2022-financial-results/ 2023-03-24T12:12:19+00:00 https://medicaex.com/prnewswire/transcenta-announces-first-patient-dosed-in-the-u-s-study-of-its-first-in-class-gremlin1-targeting-antibody-tst003-for-the-treatment-of-solid-tumors/ 2023-03-24T05:12:20+00:00 https://medicaex.com/prnewswire/ema-validates-marketing-authorization-application-for-henlius-hansizhuang-serplulimab/ 2023-03-24T01:13:05+00:00 https://medicaex.com/prnewswire/transcenta-to-present-two-preclinical-studies-at-aacr-2023/ 2023-03-24T00:12:54+00:00 https://medicaex.com/prnewswire/aquavit-awarded-10m-in-damages-on-intellectual-property-against-counterfeiters/ 2023-03-23T20:12:25+00:00 https://medicaex.com/prnewswire/innovating-for-better-sleep/ 2023-03-23T13:12:25+00:00 https://medicaex.com/prnewswire/affamed-technologies-announces-tfda-approval-of-mini-well-mini-well-proxa-mini-well-toric-and-mini-4-ready-iols-for-cataract-treatment-in-taiwan/ 2023-03-23T13:12:25+00:00 https://medicaex.com/prnewswire/ascentage-pharma-announces-2022-annual-results-including-strong-sales-of-olverembatinib-and-steady-progress-in-transition-towards-biopharma/ 2023-03-23T13:12:20+00:00 https://medicaex.com/prnewswire/jacobio-pharma-announces-2022-annual-results/ 2023-03-23T13:12:20+00:00 https://medicaex.com/prnewswire/daewoong-pharmaceuticals-envlo-to-enter-the-global-market-in-full-swing-with-filing-for-product-license-in-three-asean-countries/ 2023-03-23T12:12:36+00:00 https://medicaex.com/prnewswire/biosion-bispecific-antibody-therapies-to-be-featured-at-the-american-association-for-cancer-research-aacr-annual-meeting-2023/ 2023-03-23T09:12:20+00:00 https://medicaex.com/prnewswire/sisram-medical-ltd-to-announce-full-year-2022-financial-results-on-march-21-2023/ 2023-03-23T07:12:24+00:00 https://medicaex.com/prnewswire/wuxi-biologics-reports-remarkable-2022-annual-results/ 2023-03-23T06:12:16+00:00 https://medicaex.com/prnewswire/3sbio-announces-2022-annual-results-with-revenue-rising-7-5-year-on-year-and-normalized-net-profit-attributable-to-parents-jumping-25-2/ 2023-03-22T16:12:26+00:00 https://medicaex.com/prnewswire/debiopharm-announces-launch-of-the-phase-1-2-galuci-study-for-its-ca-ix-targeted-radiopharmaceutical-program/ 2023-03-22T13:12:18+00:00 https://medicaex.com/prnewswire/vrworkout-launches-a-future-of-fitness-experience-revolutionizing-workouts-with-controller-free-gameplay/ 2023-03-22T13:12:13+00:00 https://medicaex.com/prnewswire/nav1-7-selective-inhibitor-olp-1002-shows-strong-efficacy-and-long-therapeutic-duration-according-to-interim-findings-from-a-phase-2a-study-in-oa-patients/ 2023-03-22T12:12:29+00:00 https://medicaex.com/prnewswire/karyopharm-and-menarini-group-receive-full-marketing-authorization-from-the-uk-medicines-healthcare-products-regulatory-agency-for-nexpovio-selinexor-in-combination-with-bortezomib-and-d/ 2023-03-22T12:12:21+00:00 https://medicaex.com/prnewswire/mindset-health-raises-us12m-to-expand-digital-hypnotherapy-apps-scale-distribution/ 2023-03-22T12:12:19+00:00 https://medicaex.com/prnewswire/illumina-launches-its-first-product-enabling-long-and-short-read-sequencing-on-one-instrument/ 2023-03-22T09:12:21+00:00 https://medicaex.com/prnewswire/medical-park-hospitals-group-md-assoc-prof-neurosurgeon-sait-ozturk-has-successfully-accomplished-brain-pacemaker-surgery-while-awake-and-watching-cartoons-to-dystonia-patient-zeynep/ 2023-03-22T07:12:22+00:00 https://medicaex.com/prnewswire/two-component-recombinant-covid-19-vaccine-recov-granted-with-emergency-use-authorization-in-mongolia/ 2023-03-22T07:12:17+00:00 https://medicaex.com/prnewswire/bridge-biotherapeutics-to-present-updated-preclinical-data-of-bbt-207-at-the-aacr-2023-annual-meeting/ 2023-03-22T04:12:25+00:00 https://medicaex.com/prnewswire/bla-accepted-in-china-for-boan-biotechs-denosumab-injection-ba1102-for-the-oncology-indications/ 2023-03-22T04:12:16+00:00 https://medicaex.com/prnewswire/serviers-pivotal-phase-3-indigo-trial-investigating-vorasidenib-in-idh-mutant-low-grade-glioma-meets-primary-endpoint-of-progression-free-survival-pfs-and-key-secondary-endpoint-of-time-to-next-in/ 2023-03-22T01:12:33+00:00 https://medicaex.com/prnewswire/innovent-announces-clinical-data-of-multiple-trials-will-be-presented-at-the-aacr-annual-meeting-2023/ 2023-03-22T01:12:28+00:00 https://medicaex.com/prnewswire/gc-biopharma-receives-who-pre-qualification-for-barycela/ 2023-03-22T01:12:16+00:00 https://medicaex.com/prnewswire/magassist-revealed-in-medtech-outlooks-top-10-medtech-companies-in-apac-region-for-2022/ 2023-03-21T21:12:22+00:00 https://medicaex.com/prnewswire/sirnaomics-to-present-latest-developments-in-polypeptide-nanoparticle-platform-at-the-4th-annual-rnai-based-therapeutics-summit/ 2023-03-21T21:12:17+00:00 https://medicaex.com/prnewswire/forests-reduce-health-risks-new-global-report-confirms/ 2023-03-21T15:12:17+00:00 https://medicaex.com/prnewswire/restore-the-foundation-for-reconstructive-surgery-15th-anniversary-fundraiser-dinner-gala/ 2023-03-21T14:12:15+00:00 https://medicaex.com/prnewswire/hummingbird-bioscience-to-present-two-posters-on-her3-targeting-therapeutics-at-american-association-for-cancer-research-aacr-meeting-2023/ 2023-03-21T12:12:32+00:00 https://medicaex.com/prnewswire/transcenta-holding-limited-6628-hk-to-hold-2022-annual-results-release-conference-call/ 2023-03-21T12:12:21+00:00 https://medicaex.com/prnewswire/zepp-health-corporation-reports-fourth-quarter-and-full-year-2022-unaudited-financial-results/ 2023-03-21T12:12:13+00:00 https://medicaex.com/prnewswire/so-young-reports-unaudited-fourth-quarter-and-fiscal-year-2022-financial-results/ 2023-03-21T10:12:19+00:00 https://medicaex.com/prnewswire/amaris-b-clinic-wins-merz-aesthetics-golden-record-local-injectables-award-in-2023/ 2023-03-21T09:12:18+00:00